Wednesday, March 4, 2015
YOLO COUNTY NEWS
99 CENTS

Novozymes, Monsanto announce new $300 million pact

By
From page A3 | December 11, 2013 |

Two companies that are international powerhouses in the bioagricultural field — both of which have long-standing research-and-development operations in Davis, employing dozens of Ph.D.s — announced a $300 million cooperative agreement Tuesday.

Novozymes and Monsanto will enter into “a long-term strategic alliance to transform research and commercialization of sustainable microbial products that will provide a new platform of solutions for growers around the world,” according to the announcement, datelined Copenhagen (where Novozymes is based) and St. Louis (where Monsanto’s headquarters are located).

“The BioAg Alliance is unique in the industry, bringing together Novozymes’ commercial bio-ag operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities,” the statement said.

A Novozymes spokesperson told The Enterprise that some of the research under the BioAg Alliance will be done in Davis, but added, “It’s too early to tell exactly where the work will be done. Novozymes and Monsanto both have talented BioAg R&D teams around the world and we will be thinking about how to use our sites and talents in the best way to bring new products to market.

“We will still rely on colleagues across the global R&D organization for the important work necessary for success,” the spokesperson said. “As part of our evaluation, we will also consider our future talent needs.“

Said Peder Holk Nielsen, CEO of Novozymes, “Today, we forge a game-changing alliance with the potential to transform global agriculture. The combined capabilities of Novozymes and Monsanto create an innovation powerhouse with a unique opportunity and approach to unleash the transformational opportunity in naturally derived microbial solutions in agriculture.”

And Robb Fraley, chief technology officer of Monsanto, said, “Monsanto, Novozymes and the farmer customers we serve share a need to meet growing demand in a sustainable way, and investing in the research and development of agricultural biological technologies like microbials is another step in that direction and a natural extension of our core business.”

The statement portrayed the new alliance as mutually complementary.

Over the past decade, Novozymes has “leveraged its know-how and experience in industrial enzymes and microbial technologies to build global positions in the agricultural biologicals market with a broad and proven product portfolio,” the news release said. Novozymes’ annual revenue in 2012 neared $120 million.

“Combining its strengths within microbial discovery, application development and fermentation and its leadership position in the agricultural biologicals market, Novozymes brings an established and unique starting point for the alliance to accelerate from in both the short and long term,” the release added.

Monsanto has a research team working on microbial solutions and has one of the most extensive seeds and traits discovery, field-testing and commercial footprints in the industry, the statement said.

“All this will help accelerate microbial development through the alliance, enabling more farmers to get more solutions, faster. Last year the company introduced its agricultural biologicals platform and earlier this year acquired the assets of the agricultural company Agradis Inc. as it builds out its discovery capabilities in the microbial space.”

Under the new collaboration:

* “Monsanto and Novozymes will maintain independent and complementary internal and external discovery research programs to identify microbial targets with the potential to help farmers.”

* “Novozymes will be responsible for production and supply of the microbial solutions to Monsanto, building on its expertise within fermentation. Monsanto will serve as the lead for field testing, registration and commercialization of all alliance products.”

* “The companies will co-manage the alliance and co-fund research and development efforts.”

* “Monsanto will pay Novozymes an aggregate upfront payment of $300 million net in recognition of Novozymes’ ongoing business and microbial capabilities, and for Novozymes to supply alliance products.”

The statement indicated “Marketing responsibility for Novozymes’ current product portfolio in agricultural biologicals will be transferred to Monsanto, along with much of the Novozymes commercial organization currently responsible for that work. The two companies will work to ensure that existing customer relationships and know-how are maintained and further built on for short- and long-term success.”

Both companies “will benefit from profits on commercialized products resulting from this alliance and those products brought into the alliance by the parties. Through the alliance, the companies will also test and sell commercial microbial products purchased from other suppliers to bring additional value to farmers,” according to the statement.

The agreement is subject to the approval of national antitrust authorities. The alliance is expected to close in early 2014. Further terms of the alliance were not disclosed.

Comments

comments

.

News

Davisite competing for breast cancer ‘Survivor of the Year’

By Anne Ternus-Bellamy | From Page: A1 | Gallery

 
Cool musicians, hot jazz at Coconut Grove fundraiser

By Enterprise staff | From Page: A1 | Gallery

Guilty verdict in child abduction case

By Anne Ternus-Bellamy | From Page: A1

 
Moore featured at two climate talks this week

By Enterprise staff | From Page: A3

 
Talk breast cancer with oncologic surgeon

By Enterprise staff | From Page: A3

DPNS offers open house Saturday

By Enterprise staff | From Page: A3

 
Public input sought Monday on Northstar Pond

By Enterprise staff | From Page: A3 | Gallery

Veggie gardening, composting are workshop topics

By Enterprise staff | From Page: A3

 
Documentary on immigration issues will be screened

By Special to The Enterprise | From Page: A3

Visiting prof will discuss Armenian genocide

By Enterprise staff | From Page: A3

 
Holmes plans open house Thursday

By Enterprise staff | From Page: A3

Nominees sought for Bill Streng Business Award

By Enterprise staff | From Page: A3

 
Museum brick sales to end this month

By Enterprise staff | From Page: A3

Prostate cancer group looks at massage

By Special to The Enterprise | From Page: A3

 
Closing education gap will lift economy, a study finds

By New York Times News Service | From Page: A4 | Gallery

Applications due for Rotary’s leadership camp

By Enterprise staff | From Page: A4

 
Project Linus meets March 11

By Enterprise staff | From Page: A4

Breakfast with the Bunny tickets on sale now

By Enterprise staff | From Page: A5 | Gallery

 
.

Forum

It was music to our ears

By Letters to the Editor | From Page: A6

 
Thanks for pet drive support

By Letters to the Editor | From Page: A6

Story was an ad for NRA

By Letters to the Editor | From Page: A6

 
Athletes just want time to do their homework

By Special to The Enterprise | From Page: A6

Let’s not delete Giovanni Barovetto from Davis history

By Rich Rifkin | From Page: A6 | Gallery

 
Low-flow toilets in our parks?

By Letters to the Editor | From Page: A6

.

Sports

DHS girls lacrosse coach likes her 2015 squad

By Dylan Lee | From Page: B1 | Gallery

 
Hawkins enters the home stretch of brilliant UCD career

By Bruce Gallaudet | From Page: B1 | Gallery

Blue Devils girls stay undefeated ahead of league opener

By Evan Ream | From Page: B1 | Gallery

 
Sports briefs: Blue Devils drop softball opener

By Enterprise staff | From Page: B3

Cousins returns to lift Kings in New York

By The Associated Press | From Page: B3 | Gallery

 
San Jose crushes Canucks behind Nieto

By The Associated Press | From Page: B3

 
.

Features

Ringing in the Year of the Sheep with dim sum

By Ann Evans | From Page: A8 | Gallery

 
.

Arts

 
French-Algerian guitarist weaves acoustic spells at The Palms on Friday March 6

By Special to The Enterprise | From Page: A7 | Gallery

California Honeydrops drop in for ‘Down Home’ tour

By Landon Christensen | From Page: A7 | Gallery

 
.

Business

.

Obituaries

Merna Petersen

By Special to The Enterprise | From Page: A4

 
.

Comics

Comics: Wednesday, March 4, 2015

By Creator | From Page: B6